(Reuters) - The U.S. Food and Drug Administration said on Wednesday that it had approved Pfizer Inc's drug, Xeljanz, to treat adults with moderate-to-severe active ulcerative colitis.
LONDON (Reuters) - Cut-price copies of expensive biotech drugs promise to slash the cost of treating serious diseases, including cancer, in rich and poor countries alike - but uneven regulation has created a lopsided market.
(Reuters) - Women's healthcare company TherapeuticsMD Inc won its first-ever U.S. approval on Wednesday with the drug regulator clearing its hormone therapy for a painful condition triggered by menopause after rejecting it a year earlier.
NEW YORK (Reuters) - Drugmaker Allergan Plc plans to sell off its women's health and infectious disease businesses as Chief Executive Brent Saunders works to end the steep slide in its share price over the last year.
MUMBAI (Reuters) - India’s drug regulator plans to finalize new rules for clinical trials in a couple of months that would shorten the review time, a senior official said on Wednesday, aiming to boost clinical research in the country after interest in recent years waned.
(Reuters) - The U.S. Food and Drug Administration approved TherapeuticsMD Inc's hormone therapy for a painful condition triggered by menopause, the women's health company said on Wednesday.
GENEVA (Reuters) - China has overtaken the United States in healthy life expectancy at birth for the first time, according to World Health Organization data.
(Reuters) - AstraZeneca's first respiratory biological medicine Fasenra failed to meet its main target in a second clinical trial treating patients with moderate to very severe chronic obstructive pulmonary disease (COPD).
(Reuters) - WellCare Health Plans Inc said on Tuesday it would buy Meridian Health Plans of Michigan and Illinois for $2.5 billion in cash to become the top Medicaid provider in those states.
(Reuters Health) - It's hard to say whether creams, moisturizers or other preventive measures might help protect workers in many industries from skin damage on their hands that can lead to painful blisters, cracks and infections, a research review suggests.